01841cam a22003494a 450000100090000000300040000900500170001300800410003001000170007101600200008802000280010802000180013603500230015404000450017704200080022205000220023006000250025206000220027708200200029924500640031925000120038326000410039530000460043649000430048250400510052550506840057665000490126065000240130970000200133383000470135385600910140014140219OSt20200303151523.0051013s2006    nyua     b    001 0 eng    a  20050558817 a1012598572DNLM  a1574448277 (alk. paper)  a9781574448276  a(OCoLC)ocm62123300  aDNLM/DLCcDLCdYDXdNLMdBAKERdMUQdDLC  apcc00aRC377b.H287 200610aW1bNE33LD v.80 200610aWL 360bH236 200600a616.834 COO22300aHandbook of multiple sclerosis /cedited by Stuart D. Cook.  a4th ed.  aNew York :bTaylor & Francis,c2006.  axix, 511 p. :bill. (some col.) ;c27 cm.1 aNeurological disease and therapy ;v80  aIncludes bibliographical references and index.  aEtiopathegenesis and Epidemiology: Clues to Etiology. Genetics: Susceptibility and Expressivity. Evidence for An Infectious Etiology. An autoimmune disease of the CNS? Clinical Features of MS. MRI Techniques in MS: Role in Diagnosis, Pathophysiology and Therapy. MS Biomarkers. Evoked Potentials. Managing the Symptoms of MS. Rehabilitation: Its Role in MS. Acute Treatments. Treatment of the Clinically Isolated Syndrome. The Use of Interferon Beta. Glatiramer Acetate. Mitoxantrone. Monoclonal Antibodies, T-Cell Receptors, and T-Cell Vaccines. Immune Therapy: Altered Peptide Ligands and Statins. Immunosuppression. Combination Therapy. Regeneration Strategies. Axonal Injury. 0aMultiple sclerosisvHandbooks, manuals, etc.12aMultiple Sclerosis.1 aCook, Stuart D. 0aNeurological disease and therapy ;vv. 80.423Publisher descriptionuhttp://www.loc.gov/catdir/enhancements/fy0668/2005055881-d.html